Delcath Systems names Vojislav Vukovic as Chief Medical Officer

Delcath Systems is pleased to announce the appointment of Dr. Vojislav “Vojo” Vukovic as its new Chief Medical Officer. Dr. Vukovic is an experienced drug development executive with a distinguished career in cancer research and global clinical development. His experience spans early to late-stage oncology clinical projects and global medical affairs programs across multiple anti-cancer modalities and tumor types. He has held the position of Senior Vice President and Chief Medical Officer at Aileron Therapeutics, Taiho Oncology Inc., and Synta Pharmaceuticals Inc. overseeing various facets of clinical development, medical affairs and corporate strategy.